Browse by Nurse Practitioner Items
Nurse practitioner PBS prescribing
MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS
From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners). Information for nurse practitioners to become authorised PBS prescribers is available from Services Australia.
The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.
PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.
The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.
Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:
- Continuing therapy only model
Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)
- Shared care model
Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.
Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.
Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.
Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms. For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms. Nurse practitioner PBS prescriptions may include repeats.
Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.
Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Services Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)
State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.
- MPMedical Practitioner
- NPNurse Practitioner
|Prescriber code||Item code||Name, manner of administration and form & strength||Max qty
|MPNP||8064K||VALACICLOVIRvalaciclovir 500 mg tablet, 42||1||42||0|
|MPNP||5480K||VALACICLOVIRvalaciclovir 500 mg tablet, 30||1||30||5|
|MPNP||8134D||VALACICLOVIRvalaciclovir 500 mg tablet, 30||1||30||5|
|MPNP||8133C||VALACICLOVIRvalaciclovir 500 mg tablet, 10||2||20||0|
|MPNP||10277X||VALGANCICLOVIRvalganciclovir 50 mg/mL powder for oral liquid, 100 mL||11||11||5|
|MPNP||10306K||VALGANCICLOVIRvalganciclovir 450 mg tablet, 60||2||120||5|
|MPNP||9434M||VALINE WITH CARBOHYDRATEvaline with carbohydrate containing 1 g valine oral liquid: powder for, 30 x 4 g sachets||4||4||5|
|MPNP||9135T||VALINE WITH CARBOHYDRATEvaline with carbohydrate containing 50 mg valine oral liquid: powder for, 30 x 4 g sachets||4||4||5|
|MPNP||2289L||VALPROATEvalproate sodium 200 mg enteric tablet, 100||2||200||2|
|MPNP||2293Q||VALPROATEvalproate sodium 200 mg/5 mL oral liquid, 300 mL||2||2||2|
|MPNP||2295T||VALPROATEvalproate sodium 200 mg/5 mL oral liquid, 300 mL||2||2||2|
|MPNP||2290M||VALPROATEvalproate sodium 500 mg enteric tablet, 100||2||200||2|
|MPNP||2294R||VALPROATEvalproate sodium 100 mg tablet, 100||2||200||2|
|MPNP||9368C||VALSARTANvalsartan 40 mg tablet, 28||1||28||0|
|MPNP||9370E||VALSARTANvalsartan 160 mg tablet, 28||1||28||5|
|MPNP||9369D||VALSARTANvalsartan 80 mg tablet, 28||1||28||5|
|MPNP||9371F||VALSARTANvalsartan 320 mg tablet, 28||1||28||5|
|MPNP||9481B||VALSARTAN + HYDROCHLOROTHIAZIDEvalsartan 320 mg + hydrochlorothiazide 12.5 mg tablet, 28||1||28||5|
|MPNP||9374J||VALSARTAN + HYDROCHLOROTHIAZIDEvalsartan 160 mg + hydrochlorothiazide 25 mg tablet, 28||1||28||5|
|MPNP||9373H||VALSARTAN + HYDROCHLOROTHIAZIDEvalsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 28||1||28||5|
|MPNP||9482C||VALSARTAN + HYDROCHLOROTHIAZIDEvalsartan 320 mg + hydrochlorothiazide 25 mg tablet, 28||1||28||5|
|MPNP||9372G||VALSARTAN + HYDROCHLOROTHIAZIDEvalsartan 80 mg + hydrochlorothiazide 12.5 mg tablet, 28||1||28||5|
|MPNP||5469W||VARENICLINEvarenicline 1 mg tablet, 56||1||56||2|
|MPNP||9129L||VARENICLINEvarenicline 1 mg tablet, 56||2||112||0|
|MPNP||9128K||VARENICLINEvarenicline 500 microgram tablet  (&) varenicline 1 mg tablet , 53||1||1||0|
|MPNP||8868R||VENLAFAXINEvenlafaxine 37.5 mg modified release capsule, 28||1||28||0|
|MPNP||8302Y||VENLAFAXINEvenlafaxine 150 mg modified release capsule, 28||1||28||5|
|MPNP||8301X||VENLAFAXINEvenlafaxine 75 mg modified release capsule, 28||1||28||5|
|MPNP||1250T||VERAPAMILverapamil hydrochloride 80 mg tablet, 100||1||100||5|
|MPNP||2208F||VERAPAMILverapamil hydrochloride 180 mg modified release tablet, 30||1||30||5|
|MPNP||1241H||VERAPAMILverapamil hydrochloride 240 mg modified release tablet, 30||1||30||5|
|MPNP||1248Q||VERAPAMILverapamil hydrochloride 40 mg tablet, 100||1||100||5|
|MPNP||2668K||VIGABATRINvigabatrin 500 mg powder for oral liquid, 60 sachets||1||60||5|
|MPNP||2667J||VIGABATRINvigabatrin 500 mg tablet, 100||1||100||5|
|MPNP||3415R||VILDAGLIPTINvildagliptin 50 mg tablet, 60||1||60||5|
|MPNP||5476F||VILDAGLIPTIN + METFORMINvildagliptin 50 mg + metformin hydrochloride 1 g tablet, 60||1||60||5|
|MPNP||5475E||VILDAGLIPTIN + METFORMINvildagliptin 50 mg + metformin hydrochloride 850 mg tablet, 60||1||60||5|
|MPNP||5474D||VILDAGLIPTIN + METFORMINvildagliptin 50 mg + metformin hydrochloride 500 mg tablet, 60||1||60||5|
|MPNP||11200L||VITAMINS, MINERALS AND TRACE ELEMENTSvitamins, minerals and trace elements powder for oral liquid, 30 x 7 g sachets||1||1||5|
|MPNP||9328Y||VITAMINS, MINERALS AND TRACE ELEMENTS WITH CARBOHYDRATEvitamins, minerals and trace elements with carbohydrate powder for oral liquid, 200 g||6||6||5|
|MPNP||10149E||VITAMINS, MINERALS AND TRACE ELEMENTS WITH CARBOHYDRATEvitamins, minerals and trace elements with carbohydrate powder for oral liquid, 30 x 6 g sachets||1||1||5|
|MPNP||10198R||VORICONAZOLEvoriconazole 200 mg tablet, 56||1||56||0|
|MPNP||9364W||VORICONAZOLEvoriconazole 200 mg tablet, 56||1||56||2|
|MPNP||10173K||VORICONAZOLEvoriconazole 50 mg tablet, 56||1||56||0|
|MPNP||9363T||VORICONAZOLEvoriconazole 50 mg tablet, 56||1||56||2|
|MPNP||10168E||VORICONAZOLEvoriconazole 40 mg/mL powder for oral liquid, 70 mL||1||1||0|
|MPNP||9452L||VORICONAZOLEvoriconazole 40 mg/mL powder for oral liquid, 70 mL||1||1||0|